Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Doubt and Unbelief

Who knows what the future holds for PTSC. It was once rumored that our BoD promised Chuck Moore no settlement with TPL without a settlement for Chuck. It was believed that our BoD may have subsequently "thrown Chuck under the bus" when they settled without him. Chuck has since settled his lawsuit with TPL and is now receiving, I believe, $250K annually (from PDS) as a consulting fee. Who knows if PTSC was instrumental in negotiating a settlement between TPL and Chuck because the future of PTSC may ultimately be in a joint venture with GreenArrays.

Just my thoughts

From GreenArrays Website:

Future Directions

We are committed to continually improving our technology, and this commitment is reflected by an ongoing program of Research and Development in new processes, new capabilities, and new approaches to computer design that will facilitate novel applications. The emphasis is always on increased performance, increased efficiency, and on versatile and simple programming. Some of this work is evolutionary, meaning that it may lead to generally upward compatible improvements in our existing architectures. Some is frankly revolutionary, such as introducing entirely new computers. When we can share the status of these efforts without compromising our position, we shall do so and will appreciate feedback.

This section documents new design perspectives that are still in the process of refinement and which may, or may not, be expressed in future products. Anyone whose entrepreneurial goals call for greater commitment or more rapid development is invited to collaborate with us through a suitable vehicle such as funding, investment, or possible joint ventures; please contact Business Development to explore options.

http://www.greenarraychips.com/home/documents/roadmap.html

Share
New Message
Please login to post a reply